Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jovan Antovic

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Research and Practice in Thrombosis and Haemostasis|March 9, 2026
Normalization of activated partial thromboplastin time and diluted Russell's viper venom time ratios can be safely omitted in the assessment of lupus anticoagulantAdrian Kimiaei, Jovan Antovic, Charlotte Gran
Journal of Neurotrauma|February 1, 2007
Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markersMichael Nekludov, Jovan Antovic, Sixteen Bredbacka, et al.
Immunology Letters|October 14, 2025
High complement expression on extracellular vesicles in Covid-19 patients without pulmonary embolism leading to death. Case reportApostolos Taxiarchis, Jovan Antovic, Olav Rooyackers, et al.
Blood|March 21, 2002
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?Johanna S Ungerstedt, Sam Schulman, Nils Egberg, et al.
Thrombosis Research|November 1, 2011
Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled studyFariborz Mobarrez, Nils Egberg, Jovan Antovic, et al.
International Journal of Laboratory Hematology|September 15, 2021
Using a low-molecular weight heparin-calibrated anti-factor Xa assay to assess the concentration of apixaban and rivaroxabanHenrik von Horn, Agnes Rasmusson, Lisbeth Söderblom, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 25, 2020
Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia AYanan Zong, Aleksandra Antovic, Nida Mahmoud Hourani Soutari, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 17, 2026
Impaired clot formation and hemostasis in experimental traumatic hemorrhage modelMarcus Wannberg, Iva Pruner, Apostolos Taxiarchis, et al.
Thrombosis Research|April 9, 2019
Correlation of thromboelastography and thrombin generation assays in warfarin-treated patientsDavid E Schmidt, Roza Chaireti, Maria Bruzelius, et al.
Lakartidningen|March 21, 2018
Anna Ågren, Jovan Antovic, Karin Strandberg, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Research and Practice in Thrombosis and Haemostasis|March 9, 2026
Normalization of activated partial thromboplastin time and diluted Russell's viper venom time ratios can be safely omitted in the assessment of lupus anticoagulantAdrian Kimiaei, Jovan Antovic, Charlotte Gran
Journal of Neurotrauma|February 1, 2007
Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markersMichael Nekludov, Jovan Antovic, Sixteen Bredbacka, et al.
Immunology Letters|October 14, 2025
High complement expression on extracellular vesicles in Covid-19 patients without pulmonary embolism leading to death. Case reportApostolos Taxiarchis, Jovan Antovic, Olav Rooyackers, et al.
Blood|March 21, 2002
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?Johanna S Ungerstedt, Sam Schulman, Nils Egberg, et al.
Thrombosis Research|November 1, 2011
Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled studyFariborz Mobarrez, Nils Egberg, Jovan Antovic, et al.
International Journal of Laboratory Hematology|September 15, 2021
Using a low-molecular weight heparin-calibrated anti-factor Xa assay to assess the concentration of apixaban and rivaroxabanHenrik von Horn, Agnes Rasmusson, Lisbeth Söderblom, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 25, 2020
Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia AYanan Zong, Aleksandra Antovic, Nida Mahmoud Hourani Soutari, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 17, 2026
Impaired clot formation and hemostasis in experimental traumatic hemorrhage modelMarcus Wannberg, Iva Pruner, Apostolos Taxiarchis, et al.
Thrombosis Research|April 9, 2019
Correlation of thromboelastography and thrombin generation assays in warfarin-treated patientsDavid E Schmidt, Roza Chaireti, Maria Bruzelius, et al.
Lakartidningen|March 21, 2018
Anna Ågren, Jovan Antovic, Karin Strandberg, et al.
Pageof 4